Metabolic diversity in myxobacteria: Identification of the myxalamid and the stigmatellin biosynthetic gene cluster of Stigmatella aurantiaca Sg a15 and a combined polyketide-(poly)peptide gene cluster from the epothilone producing strain Sorangium cellulosum So ce90

Biochimica et Biophysica Acta - Gene Structure and Expression

Volumn 1445, Issue 2, 1999, Pages 185-195

  Beyer, Stefan ^a   Kunze, Brigitte ^a   Silakowski, Barbara ^a   Müller, Rolf ^a,b  

^a HELMHOLTZ CENTRE FOR INFECTION RESEARCH   (Germany)

^b UNIVERSITY OF BONN   (Germany)

Author keywords

Combinatorial biosynthesis; Myxobacterium; Non ribosomal peptide synthetase; Polyketide synthase; Screening; Secondary metabolism

Indexed keywords

EPOTHILONE A; POLYKETIDE; STIGMATELLIN; SYNTHETASE;

ARTICLE; BIOSYNTHESIS; ENZYME ACTIVITY; ENZYME ANALYSIS; GENE CLUSTER; GENE INACTIVATION; GENE LIBRARY; GENETIC ENGINEERING; GENOME; GRAM NEGATIVE BACTERIUM; MYXOCOCCALES; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

AMINO ACID SEQUENCE; CLONING, MOLECULAR; DNA, BACTERIAL; MOLECULAR SEQUENCE DATA; MULTIENZYME COMPLEXES; MULTIGENE FAMILY; MYXOCOCCALES; PEPTIDE SYNTHASES; PLASMIDS; POLYENES; SEQUENCE ALIGNMENT;

EID: 0033553579     PISSN: 01674781     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-4781(99)00041-X     Document Type: Article

References (41)

1. Reichenbach H., Höfle G. Biologically active secondary metabolites from myxobacteria. Biotechnol. Adv. 11:1993;219-277.
2. H. Reichenbach, G. Höfle, Myxobacteria as producers of secondary metabolites, in: S. Grabley, R. Thiericke (Eds.), Drug Discovery from Nature, Springer Verlag, Berlin, 1999, pp. 149-179.
3. Höfle G., Reichenbach H. Biologically active substances from microorganisms - an interdisciplinary research project at the GBF. Sci. Annu. Rep. Ges. Biotechnol. Forsch. Braunschweig. 1990:1990;5-22.
4. Kunze B., Höfle G., Reichenbach H. The aurachins, new quinoline antibiotics from myxobacteria: production, physico-chemical and biological properties. J. Antibiot. 40:1987;258-265.
5. Kunze B., Kemmer T., Höfle G., Reichenbach H. Stigmatellin, a new antibiotic from Stigmatella aurantiaca (Myxobacterales). I. Production, physico-chemical and biological properties. J. Antibiot. 37:1984;454-461.
6. Gerth K., Jansen R., Reifenstahl G., Höfle G., Irschik H., Kunze B., Reichenbach H., Thierbach G. The myxalamids, new antibiotics from Myxococcus xanthus (Myxobacterales). I. Production, physico-chemical and biological properties and mechanism of action. J. Antibiot. 36:1983;1150-1156.
7. Gerth K., Irschik H., Reichenbach H., Trowitzsch W. Myxothiazol, an antibiotic from Myxococcus fulvus (myxobacterales). I. Cultivation, isolation, physico-chemical and biological properties. J. Antibiot. 33:1980;1474-1479.
8. Herrmann M., Böhlendorf B., Irschik H., Reichenbach H., Höfle G. Maracin und Maracen: Neuartige Ethinyl-vinylether- bzw. a-Chlordivinylether-Antibiotica aus Sorangium cellulosum mit spezifischer Wirkung gegen Mycobakterien. Angew. Chem. 110:1998;1313-1315.
9. Irschik H., Jansen R., Gerth K., Höfle G., Reichenbach H. Chivosazol A, a new inhibitor of eukaryotic organisms isolated from myxobacteria. J. Antibiot. 48:1995;962-966.
10. Höfle G., Bedorf N., Steinmetz H., Schomburg D., Gerth K., Reichenbach H. Epothilone A and B - novel 16-membered macrolides with cytotoxic activity: isolation, crystal structure and conformation in solution. Angew. Chem. Int. Ed. 35:1996;1567-1569.
11. Gerth K., Bedorf N., Höfle G., Irschik H., Reichenbach H. Epothilons A and B: antifungal and cytotoxic compounds from Sorangium cellulosum (Myxobacteria). Production, physico-chemical and biological properties. J. Antibiot. 49:1996;560-563.
12. Bollag D.M., McQueney P.A., Zhu J., Hensens O., Koupal L., Liesch J., Goetz M., Lazarides E., Woods M. Epothilones, a new class of microtubule-stabilizing agents with taxol-like mechanism of action. Cancer Res. 55:1995;2325-2333.
13. Mühlrath P.F., Sasse F. Epothilone B stabilizes microtubuli of macrophages like taxol without showing taxol-like endotoxin activity. Cancer Res. 57:1997;3344-3346.
14. H. Reichenbach, G. Höfle, Production of bioactive secondary metabolites, in: M. Dworkin, D. Kaiser (Eds.), Myxobacteria II, American Society for Microbiology, Washington, DC, 1993, pp. 347-397.
15. G. Höfle, H. Reichenbach, The biosynthetic potential of the myxobacteria, in: W. Kuhn, H.-P. Fiedler (Eds.), Sekundärmetabolismus bei Mikroorganismen, Attempto Verlag Tübingen, Tübingen, 1995, pp. 61-78.
16. Gehring A.M., Mori I., Perry R.D., Walsh C.T. The nonribosomal peptide synthetase HMWP2 forms a thiazoline ring during biogenesis of yersiniabactin, an iron-chelating virulence factor of Yersinia pestis. Biochemistry. 37:1998;11637-11650.
17. Gaisser S., Hughes C. A locus coding for putative non-ribosomal peptide/polyketide synthase functions is mutated in a swarming-defective Proteus mirabilis strain. Mol. Gen. Genet. 253:1997;415-427.
18. S. Chen, D. von Bamberg, V. Hale, M. Breuer, B. Hardt, R. Müller, H.G. Floss, K.A. Reynolds, E. Leistner, Biosynthesis of ansatrienin (mycotrienin) and naphtomycin: identification and analysis of two separate biosynthetic gene clusters in Streptomyces collinus TÜ 1892, Eur. J. Biochem. (1999) in press.
19. Schwecke T., Aparicio J.F., Molnar I., König A., Khaw L.E., Haydock S.F., Oliynyke M., Caffrey P., Cortes J., Lester J.B., Bohm G.A., Staunton J., Leadlay P.F. The biosynthetic gene cluster for the polyketide immunosuppressant rapamycin. Proc. Natl. Acad. Sci. USA. 92:1995;7839-7843.
20. R. Jansen, H. Irschik, H. Reichenbach, G. Höfle, Antibiotics from gliding bacteria, LXXX: Chivosazoles A-F: novel antifungal and cytotoxic macrolides from Sorangium cellulosum (Myxobacteria), Liebigs Ann. (1997) 1725-1732.
21. W. Trowitzsch-Kienast, E. Forche, V. Wray, H. Reichenbach, E. Jurkiewicz, G. Hunsmann, G. Höfle, Phenalamide, neue HIV-Inhibitoren aus Myxococcus stipitatus Mx s40, Liebigs Ann. (1992) 659-664.
22. Gehring A.M., DeMoll E., Fetherston J.D., Mori I., Mayhew G.F., Blattner F.R., Walsh C.T., Perry R.D. Iron acquisition in plague: modular logic in enzymatic biogenesis of yersiniabactin by Yersinia pestis. Chem. Biol. 5:1998;573-586.
23. Schupp T., Toupet C., Cluzel B., Neff S., Hill S., Beck J., Lignon J. A Sorangium cellulosum (myxobacterium) gene cluster for the biosynthesis of the macrolide antibiotic soraphen A: cloning, characterization, and homology to polyketide synthase genes from Actinomycetes. J. Bacteriol. 177:1995;3673-3679.
24. Pospiech A., Cluzel B., Bietenhader J., Schupp T. A new Myxococcus xanthus gene cluster for the biosynthesis of the antibiotic saframycin Mx1 encoding a peptide synthetase. Microbiology. 141:1995;1793-1803.
25. For an issue covering polyketide and non-ribosomal polypeptide biosynthesis see: Chem. Rev. 97 (1997) 2463-2706.
26. Katz L., Donadino S. Polyketide synthesis: prospects for hybrid antibiotics. Annu. Rev. Microbiol. 47:1993;875-912.
27. Hopwood D.A., Sherman D.H. Molecular genetics of polyketides and its comparison to fatty acid biosynthesis. Annu. Rev. Genet. 24:1990;37-66.
28. Nicolaou K., Roschangar F., Vourloumis D. Chemie und Biologie der Epothilone. Angew. Chem. 110:1998;2120-2153.
29. N.P. Keller, D. Brown, R.A.E. Butchko, M. Fernandes, H. Kelkar, C. Nesbitt, S. Segner, D. Bhatnagar, T.E. Cleveland, T.H. Adams, A conserved polyketide mycotoxin gene cluster in Aspergillus nidulans, in: J.L. Richard (Eds.), Molecular Approaches to Food Safety Issues Involving Toxic Microorganisms, vol. 18, Alaken, Fort Collins, CO, 1995, pp. 263-277.
30. Kakavas S.J., Katz L., Stassi D. Identification and characterization of the niddamycin polyketide synthase genes from Streptomyces caelestis. J. Bacteriol. 179:1997;7515-7522.
31. Turgay K., Marahiel M.A. A general approach for identifying and cloning peptide synthetase genes. Pept. Res. 7:1994;238-241.
32. MacNeil D.J., Gewain K.M., Ruby C.L., Dezeny G., Gibbons P.H., MacNeil T. Analysis of Streptomyces avermitilis genes required for avermectin biosynthesis utilizing a novel integration vector. Gene. 111:1992;61-68.
33. J. Sambrook, E.F. Fritsch, T. Maniatis, Molecular Cloning. A Laboratory Manual, 2nd edn., Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, 1989.
34. Thompson J.D., Higgins D.G., Gibson T.J. CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res. 22:1994;4673-4680.
35. Sanger F., Nicklen S., Coulson A.R. DNA sequencing with chain-terminating inhibitors. Proc. Natl. Acad. Sci. USA. 74:1977;5463-5467.
36. Oh S.H., Chater K.F. Denaturation of circular or linear DNA facilitates targeted integrative transformation of Streptomyces coelicolor A3(2): possible relevance to other organisms. J. Bacteriol. 179:1997;122-127.
37. Glomp I., Saulnier P., Guespin-Michel J., Schairer H.U. Transfer of IncP plasmids into Stigmatella aurantiaca leading to insertional mutants affected in spore development. Mol. Gen. Genet. 214:1988;213-217.
38. Konz D., Klens A., Schorgendorfer K., Marahiel M.A. The bacitracin biosynthesis operon of Bacillus licheniformis ATCC 10716: molecular characterization of three multi-modular peptide synthetases. Chem. Biol. 4:1997;927-937.
39. August P.R., Tang L., Yoon Y.J., Ning S., Müller R., Yu T.W., Taylor M., Hoffmann D., Kim C.G., Zhang X., Hutchinson C.R., Floss H.G. Biosynthesis of the ansamycin antibiotic rifamycin: deductions from the molecular analysis of the rif biosynthetic gene cluster of Amycolatopsis mediterranei S699. Chem. Biol. 5:1998;69-79.
40. Xue Y., Zhao L., Liu H.-W., Sherman D.H. A gene cluster for macrolide antibiotic biosynthesis in Streptomyces venezuelae: architecture of metabolic diversity. Proc. Natl. Acad. Sci. USA. 95:1998;12111-12116.
41. Cane D.E., Walsh C.T., Khosla C. Harnessing the biosynthetic code: combinations, permutations, and mutations. Science. 282:1998;63-68.